Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study.
Autor: | Pallisgaard, Jannik Langtved1,2 jannikjannik@gmail.com, Lindhardt, Tommi Bo1,2, Hansen, Morten Lock1,3, Schjerning, Anne-Marie1, Olesen, Jonas Bjerring1, Staerk, Laila1,2, Torp-Pedersen, Christian4, Gislason, Gunnar Hilmar1,2,5,6 |
---|---|
Zdroj: | PLoS ONE. 29/10/2015, Vol. 10 Issue 10, p1-11. 11p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |